Antiprolactinoma Effect of Hordenine by Inhibiting MAPK Signaling Pathway Activation in Rats

Figure 2

Pituitary gland imaging of rats by nuclear magnetic resonance: (a) control, (b) sham-operated control, (c) model control, (d) model + bromocriptine, (e) model + hordenine (152.8 mg/kg), (f) model + hordenine (76.4 mg/kg), and (g) model + hordenine (38.2 mg/kg).

(a)

(b)

(c)

(d)

(e)

(f)

(g)